FILE PHOTO: A person passes by on a scooter in front of the Bill & Melinda Gates Foundation in Seattle, Washington, U.S. May 5, 2021. REUTERS/Lindsey Wasson
(Reuters) - The Gates Foundation will allocate up to $120 million to help lower-income countries get an experimental COVID-19 drug being developed by U.S. drugmaker Merck & Co Inc in the battle against coronavirus, it said on Wednesday.
The money will support efforts to develop and make generic versions of what could become the first oral antiviral medication for the disease if it wins regulatory approval, the foundation said in a statement.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
